New Parkinson's drug candidate enters safety testing in china
NCT ID NCT07513441
First seen Apr 14, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This early-stage study will test a new drug called Lu AF28996 in 10 Chinese adults with Parkinson's disease. The main goal is to check if the drug is safe and how the body processes it. This is a first step to see if the drug might help control Parkinson's symptoms in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, 100070, China
-
Huashan Hospital, Fudan University
Shanghai, 200040, China
-
West China Hospital, Sichuan University
Chengdu, 610041, China
-
Xuanwu Hospital Capital Medical University
Beijing, 100053, China
Conditions
Explore the condition pages connected to this study.